Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
121.00
-2.50 (-2.02%)
Aug 1, 2025, 1:30 PM CST

Caliway Biopharmaceuticals Company Description

Caliway Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the development of drugs for aesthetic medicine and chronic inflammation.

The company develops CBL-514, an investigational drug, which is in Phase 2 clinical trial for non-surgical fat reduction and Dercum’s disease, as well as for cellulite treatment.

It is also developing CBA-539, which is in preclinical stage for central obesity, hyperpigmentation, and skin aging, as well as offers dietary supplements.

The company was incorporated in 2012 and is based in New Taipei City, Taiwan.

Caliway Biopharmaceuticals Co., Ltd.
CountryTaiwan
Founded2012
IndustryBiotechnology
SectorHealthcare
CEOYufang Ling

Contact Details

Address:
No.99, Xintai 5th Road
New Taipei City, 221
Taiwan
Phone886 2 2697 1355
Websitecaliway.com.tw

Stock Details

Ticker Symbol6919
ExchangeTaiwan Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyTWD
ISIN NumberTW0006919004
SIC Code2834

Key Executives

NamePosition
Yufang LingChief Executive Officer and Research & Development Chief
Lu-hui HsuChief Strategy Officer and Chairman